Option chain shows key data for Shuttle Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Shuttle Pharmaceuticals.

Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock, Option Chain

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Five9

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AKAM

ALTI

ANNA

CELH

DGNX

FIVN

GLOB

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

ISPO

JCTC

MLGO

MNDR

Nuveen Insured California Premium Fund Ii

SHPH

SOAR

TANH

Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Alphabet.Google.Shutterstock

AMBO

DBGI

ENSC

GLYC

GOOG

GOOGL

LGMK

NRDS

PLRZ

QRVO

RDDT

RHHBY

SNAP

SPRO

STBX

THRY

Tempest Therapeutics, Inc. - Common Stock

TPST

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Why It Matters

Earnings

Equities

Eurozone

Commodities

BKYI

EFSH

HRYU

PGHL

US Stocks Mixed; McDonald&#39;s Posts Upbeat Earnings

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals Holdings Inc

SIHUAN PHARM HOLDINGS GP by Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd

SIHUAN PHARM HLDGS ADR by Sihuan Pharmaceutical Holdings Group Ltd.

Health Care

Press Releases

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Contracts

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Management

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Financing

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

IPOs

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Legal

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

NWBO

Apollomics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Bone Biologics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Entero Therapeutics

Genprex

GRI Bio

Onconetix

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Scorpius Holdings

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Tharimmune

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

Comments

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals (SHPH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga